Detalles de la búsqueda
1.
Characterization and Management of Adverse Reactions in Patients With Advanced Endometrial Cancer Receiving Lenvatinib Plus Pembrolizumab.
Oncologist
; 29(1): 25-35, 2024 Jan 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-37523661
2.
Lenvatinib plus pembrolizumab for patients with previously treated advanced ovarian cancer: Results from the phase 2 multicohort LEAP-005 study.
Gynecol Oncol
; 186: 182-190, 2024 May 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-38718741
3.
Outcomes of Breast Cancer Patients Treated with Chemotherapy, Biologic Therapy, Endocrine Therapy, or Active Surveillance During the COVID-19 Pandemic.
Oncologist
; 27(2): 89-96, 2022 03 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35641208
4.
Lenvatinib with etoposide plus ifosfamide in patients with refractory or relapsed osteosarcoma (ITCC-050): a multicentre, open-label, multicohort, phase 1/2 study.
Lancet Oncol
; 22(9): 1312-1321, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34416158
5.
Lenvatinib plus pembrolizumab in patients with either treatment-naive or previously treated metastatic renal cell carcinoma (Study 111/KEYNOTE-146): a phase 1b/2 study.
Lancet Oncol
; 22(7): 946-958, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-34143969
6.
OLIE, ITCC-082: a Phase II trial of lenvatinib plus ifosfamide and etoposide in relapsed/refractory osteosarcoma.
Future Oncol
; 17(32): 4249-4261, 2021 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-34382412
7.
Avoidance of Care: How Healthcare Affordability Influenced COVID-19 Disease Severity and Outcomes.
Am J Epidemiol
; 2024 Mar 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-38497546
8.
Coronavirus disease 2019 vaccine skin testing and graded challenges in vaccine-hesitant patients.
Ann Allergy Asthma Immunol
; 131(1): 116-117, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37031774
9.
Pembrolizumab With or Without Lenvatinib for First-Line Metastatic NSCLC With Programmed Cell Death-Ligand 1 Tumor Proportion Score of at least 1% (LEAP-007): A Randomized, Double-Blind, Phase 3 Trial.
J Thorac Oncol
; 19(6): 941-953, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38159809
10.
Pembrolizumab with or Without Lenvatinib as First-line Therapy for Patients with Advanced Urothelial Carcinoma (LEAP-011): A Phase 3, Randomized, Double-Blind Trial.
Eur Urol
; 85(3): 229-238, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-37778952
11.
Lenvatinib Plus Pembrolizumab Versus Sunitinib in First-Line Treatment of Advanced Renal Cell Carcinoma: Final Prespecified Overall Survival Analysis of CLEAR, a Phase III Study.
J Clin Oncol
; 42(11): 1222-1228, 2024 Apr 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-38227898
12.
Lenvatinib Plus Pembrolizumab in Previously Treated Advanced Endometrial Cancer: Updated Efficacy and Safety From the Randomized Phase III Study 309/KEYNOTE-775.
J Clin Oncol
; 41(16): 2904-2910, 2023 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37058687
13.
Phase 3 CLEAR study in patients with advanced renal cell carcinoma: outcomes in subgroups for the lenvatinib-plus-pembrolizumab and sunitinib arms.
Front Oncol
; 13: 1223282, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37664025
14.
Corrigendum: Phase 3 CLEAR study in patients with advanced renal cell carcinoma: outcomes in subgroups for the lenvatinib-plus-pembrolizumab and sunitinib arms.
Front Oncol
; 13: 1343027, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-38495081
15.
Comparative results of focal-cryoablation and stereotactic body radiotherapy in the treatment of unilateral, low-to-intermediate-risk prostate cancer.
Int Urol Nephrol
; 54(10): 2529-2535, 2022 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-35864430
16.
Lenvatinib dose, efficacy, and safety in the treatment of multiple malignancies.
Expert Rev Anticancer Ther
; 22(4): 383-400, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35260027
17.
Paediatric Strategy Forum for medicinal product development of multi-targeted kinase inhibitors in bone sarcomas: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration.
Eur J Cancer
; 173: 71-90, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35863108
18.
Positively selected modifications in the pore of TbAQP2 allow pentamidine to enter Trypanosoma brucei.
Elife
; 92020 08 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-32762841
19.
Lenvatinib plus Pembrolizumab Following Immune Checkpoint Inhibitor Treatment in Patients with Metastatic Clear Cell Renal Cell Carcinoma: Results from Study 111/KEYNOTE-146.
Eur Urol
; 2024 May 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-38777648
Resultados
1 -
19
de 19
1
Próxima >
>>